Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells
Open Access
- 23 August 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (51) , 84128-84141
Abstract
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cellsKeywords
This publication has 77 references indexed in Scilit:
- The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinGenes & Nutrition, 2012
- Integrin αv Expression Is Required for the Acquisition of a Metastatic Stem/Progenitor Cell Phenotype in Human Prostate CancerThe American Journal of Pathology, 2011
- Retinoids regulate stem cell differentiationJournal of Cellular Physiology, 2010
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271Nature, 2010
- Integrin Alpha 6 Regulates Glioblastoma Stem CellsCell Stem Cell, 2010
- Key Roles for Transforming Growth Factor β in Melanocyte Stem Cell MaintenanceCell Stem Cell, 2010
- Integrin signaling through FAK in the regulation of mammary stem cells and breast cancerIUBMB Life, 2010
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Identification of cells initiating human melanomasNature, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007